JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of common stock, $0.001 par value per share, of PLx Pharma Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as Exhibit A to such Schedule 13G. In evidence thereof, the undersigned hereby execute this agreement this 6th day of April, 2023.
| PARK WEST ASSET MANAGEMENT LLC | ||
| By: | /s/ Xxxxx Xxxxxxx | |
| Name: | Xxxxx Xxxxxxx | |
| Title: | Chief Financial Officer | |
| PARK WEST INVESTORS MASTER FUND, LIMITED | ||
| By: | Park West Asset Management LLC, its Investment Manager | |
| By: | /s/ Xxxxx Xxxxxxx | |
| Name: | Xxxxx Xxxxxxx | |
| Title: | Chief Financial Officer | |
| /s/ Xxxxx X. Xxxx | ||
| Xxxxx X. Park | ||
